JPH08277209A - Revitalizing hair tonic - Google Patents

Revitalizing hair tonic

Info

Publication number
JPH08277209A
JPH08277209A JP7082122A JP8212295A JPH08277209A JP H08277209 A JPH08277209 A JP H08277209A JP 7082122 A JP7082122 A JP 7082122A JP 8212295 A JP8212295 A JP 8212295A JP H08277209 A JPH08277209 A JP H08277209A
Authority
JP
Japan
Prior art keywords
weight
parts
minoxidil
ether
hair restorer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7082122A
Other languages
Japanese (ja)
Inventor
Kenichi Suzuki
建一 鈴木
Koji Imamura
康二 今村
Susumu Morioka
進 森岡
Fumio Urushizaki
文男 漆崎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Priority to JP7082122A priority Critical patent/JPH08277209A/en
Publication of JPH08277209A publication Critical patent/JPH08277209A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE: To obtain an excellent revitalizing hair tonic by using monoxidil and a monoalkyl ether of an aliphatic polyalcohol as a transdermal absorption enhancer for monoxidil. CONSTITUTION: The transdermal absorption of monoxidil is increased by using an aliphatic monoalkylether of an aliphatic polyalcohol. Glycerin is preferred as aliphatic polyalcohol. α-Monoisostearylglycerylether is preferred as a monoalkyl ether of an aliphatic polyalcohol. In a preferred formulation, 0.5-5%.wt. of monoxidil [chemical name: 6-(1-piperidinyl)-2,4-pirimidiamine-3- oxide] is used. The amount of monoalkylether of aliphatic polyalcohol in the formulation is preferably in 1-20%.wt. This revitalizing hair tonic is used as lotion, tonic, cream, ointment and aerosol.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、ミノキシジルの経皮吸
収性を増大させた育毛剤に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a hair-growth agent having increased transdermal absorbability of minoxidil.

【0002】[0002]

【従来の技術】ミノキシジルは化学名を6−(1−ピペ
リジニル)−2,4−ピリミジンジアミン−3−オキサ
イドと称し、米国特許公報第4139619号に育毛剤
としての適用が述べられている。その米国特許公報中に
基剤成分としてプロピレングリコールを配合した処方例
などが記載されている。しかし、皮膚には薬物透過に対
する抵抗性が備わっているため、ミノキシジルを外用剤
として用いた場合、薬効発現に十分な量が吸収されにく
いという欠点があった。そのため、近年ミノキシジルの
経皮吸収性を製剤的に向上させる試みが行われてきた
が、これまで公知になっている製剤ではミノキシジルの
経皮吸収性が悪く、程度の異なる各種の脱毛症に対して
十分な効果が得られていなかった。
Minoxidil has a chemical name of 6- (1-piperidinyl) -2,4-pyrimidinediamine-3-oxide, and its application as a hair restorer is described in U.S. Pat. No. 4,139,619. In the US patent publication, a formulation example in which propylene glycol is added as a base component is described. However, since the skin has resistance to drug permeation, when minoxidil is used as an external preparation, there is a drawback that it is difficult to absorb a sufficient amount to exert its drug effect. Therefore, in recent years, attempts have been made to improve the transdermal absorbability of minoxidil as a preparation, but the transdermal absorbability of minoxidil has been poor in the hitherto known preparations, and for various types of alopecia of various types. Was not sufficiently effective.

【0003】[0003]

【発明が解決しようとする課題】本発明の目的は上記事
情を鑑み、ミノキシジルの経皮吸収性を増大させ、薬効
発現に十分な量のミノキシジルが経皮吸収される育毛剤
を提供することにある。
SUMMARY OF THE INVENTION In view of the above circumstances, an object of the present invention is to provide a hair-growth agent which increases the transdermal absorbability of minoxidil, and in which a sufficient amount of minoxidil to exert a drug effect is transdermally absorbed. is there.

【0004】[0004]

【課題を解決するための手段】本発明者らは、鋭意研究
の結果、脂肪族多価アルコールのモノアルキルエーテル
がミノキシジルの経皮吸収性を著しく高めることを見い
だし、本発明を完成した。すなわち、本発明はミノキシ
ジルおよび脂肪族多価アルコールのモノアルキルエーテ
ルを含有することを特徴とする育毛剤である。
As a result of earnest research, the present inventors have found that a monoalkyl ether of an aliphatic polyhydric alcohol significantly enhances the transdermal absorbability of minoxidil, and completed the present invention. That is, the present invention is a hair restorer characterized by containing minoxidil and a monoalkyl ether of an aliphatic polyhydric alcohol.

【0005】本発明において、脂肪族多価アルコールと
は炭素数2個から6個で、2価または3価のアルコール
である。脂肪族多価アルコールとして好ましいものにグ
リセリン、ヘキサントリオール、エチレングリコール、
プロピレングリコール、1,4−ブタンジオール、トリ
エチレングリコール、ジエチレングリコールなどがあげ
られ、最も好ましいものとしてグリセリンがあげられ
る。また、脂肪族多価アルコールとエーテル結合を為す
アルキル基として好ましいのは炭素数8から24の直鎖
状または分岐鎖状のアルキル基である。炭素鎖が8より
短くなると皮膚刺激性が増し、外用剤として好ましくな
く、炭素鎖が24より長くなると流動性が悪くなり、製
剤化が困難になる。アルキル基として好ましいものにオ
クチル基、ノニル基、デシル基、ドデシル基、テトラデ
シル基、セチル基、ステアリル基、イソステアリル基、
エイコサニル基、ドコサニル基などがあげられ、最も好
ましいものとしてイソステアリル基があげられる。
In the present invention, the aliphatic polyhydric alcohol is a divalent or trivalent alcohol having 2 to 6 carbon atoms. Glycerin, hexanetriol, ethylene glycol, and the like are preferable as the aliphatic polyhydric alcohol.
Propylene glycol, 1,4-butanediol, triethylene glycol, diethylene glycol and the like can be mentioned, and glycerin is most preferable. Further, the alkyl group which forms an ether bond with the aliphatic polyhydric alcohol is preferably a linear or branched alkyl group having 8 to 24 carbon atoms. When the carbon chain is shorter than 8, the skin irritation is increased and it is not preferable as an external preparation, and when the carbon chain is longer than 24, the fluidity is deteriorated and the formulation becomes difficult. Octyl group, nonyl group, decyl group, dodecyl group, tetradecyl group, cetyl group, stearyl group, isostearyl group to the preferred alkyl group,
Examples thereof include eicosanyl group and docosanyl group, and the most preferable one is isostearyl group.

【0006】脂肪族多価アルコールにおいて、アルキル
基とエーテル結合を為す水酸基は何れの部位の水酸基で
も構わないが、脂肪鎖の末端に位置する水酸基とエーテ
ル結合したものが最も好ましい。
In the aliphatic polyhydric alcohol, the hydroxyl group forming an ether bond with the alkyl group may be a hydroxyl group at any site, but a hydroxyl group at the terminal of the fatty chain with an ether bond is most preferred.

【0007】本発明中の脂肪族多価アルコールのモノア
ルキルエーテルが、外用剤として用いた場合に、高い安
全性を持ったもので無ければならないのは当然のことで
ある。
As a matter of course, the monoalkyl ether of the aliphatic polyhydric alcohol used in the present invention must have high safety when used as an external preparation.

【0008】本発明では、ミノキシジルの配合量は製剤
全体に対して0.1〜5重量%が好ましく、さらに好ま
しくは0.5〜2重量%である。脂肪族多価アルコール
のモノアルキルエーテルの配合量は1〜20重量%が好
ましく、さらに好ましくは2〜10重量%である。また
その他の成分としては通常育毛剤に用いられる賦形剤、
血管拡張剤(塩化カルプロニウム、ニコチン酸ベンジ
ル、センブリ抽出液、オタネニンジンエキス、ビタミン
Eアセテート、トウガラシチンキなど)、副腎皮質ホル
モン(酢酸ヒドロコルチゾン、酪酸プロピオン酸ヒドロ
コルチゾンなど)、抗ヒスタミン剤(塩酸ジフェンヒド
ラミン、塩酸イソチペンジルなど)、抗炎症剤(グリチ
ルレチン酸、グアイアズレンなど)、角質溶解剤(尿
素、サリチル酸など)、殺菌剤(グルコン酸クロルヘキ
シジン、イソプロピルメチルフェノール、第4級アンモ
ニウム塩、ヒノキチオール、ピロクトンオラミンな
ど)、保湿剤(ヒアルロン酸ナトリウム、グリセリン、
コンドロイチン硫酸など)、各種動植物(イチイ、ボタ
ンピ、カンゾウ、オトギリソウ、附子、ビワ、カワラヨ
モギ、コンフリー、アシタバ、サフラン、サンシシ、ロ
ーズマリー、セージ、モッコウ、セイモッコウ、ホッ
プ、プラセンタなど)の抽出物、ビタミン類(酢酸レチ
ノール、塩酸ピリドキシン、アスコルビン酸、硝酸チア
ミン、シアノコバラミン、ビオチンなど)、油分(ミリ
スチン酸イソプロピル、パルミチン酸イソプロピル、ス
クワラン、流動パラフィン、レシチンなど)、界面活性
剤(ポリオキシエチレンソルビタン脂肪酸エステル、ソ
ルビタン脂肪酸エステル、ポリオキシエチレン脂肪酸エ
ステル、グリセリン脂肪酸エステル、プロピレングリコ
ール脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油
など)、多価アルコール(プロピレングリコール、1,
3−ブタンジオール、マクロゴール、ジプロピレングリ
コールなど)、精油(メントール、カンフルなど)、抗
酸化剤(ジブチルヒドロキシトルエン、イソプロピルガ
レートなど)、金属イオン封鎖剤(エチレンジアミンテ
トラアセテートまたはその塩)、色素、香料などを、本
発明の組成物の効果を損なわない範囲で配合することが
できる。
In the present invention, the content of minoxidil is preferably 0.1 to 5% by weight, more preferably 0.5 to 2% by weight, based on the whole preparation. The compounding amount of the monoalkyl ether of the aliphatic polyhydric alcohol is preferably 1 to 20% by weight, more preferably 2 to 10% by weight. As other ingredients, excipients usually used in hair restorers,
Vasodilators (carpronium chloride, benzyl nicotinate, senburi extract, ginseng extract, vitamin E acetate, capsicum tincture, etc.), corticosteroids (hydrocortisone acetate, hydrocortisone propionate butyrate, etc.), antihistamines (diphenhydramine hydrochloride, isothipendyl hydrochloride, etc.) , Anti-inflammatory agents (glycyrrhetinic acid, guaizulene, etc.), keratolytic agents (urea, salicylic acid, etc.), bactericides (chlorhexidine gluconate, isopropylmethylphenol, quaternary ammonium salts, hinokitiol, piroctone olamine, etc.), moisturizers (Sodium hyaluronate, glycerin,
Chondroitin sulphate, etc.), extracts of various plants and animals (yew, button pipi, licorice, St. John's wort, konjac, loquat, sagebrush, comfrey, ashitaba, saffron, sardine, rosemary, sage, mokko, samokko, hops, placenta, etc.), vitamins Kinds (retinol acetate, pyridoxine hydrochloride, ascorbic acid, thiamine nitrate, cyanocobalamin, biotin, etc.), oil (isopropyl myristate, isopropyl palmitate, squalane, liquid paraffin, lecithin, etc.), surfactant (polyoxyethylene sorbitan fatty acid ester, Sorbitan fatty acid ester, polyoxyethylene fatty acid ester, glycerin fatty acid ester, propylene glycol fatty acid ester, polyoxyethylene hydrogenated castor oil, etc.), polyhydric alcohol Le (propylene glycol, 1,
3-butanediol, macrogol, dipropylene glycol, etc.), essential oils (menthol, camphor, etc.), antioxidants (dibutylhydroxytoluene, isopropyl gallate, etc.), sequestering agents (ethylenediaminetetraacetate or its salts), dyes, Fragrances and the like can be added within a range that does not impair the effects of the composition of the present invention.

【0009】本発明の育毛剤はローション剤、トニック
剤、クリーム剤、軟膏剤、エアゾール剤などの外用製剤
を常法に従って製造することができる。
The hair restorer of the present invention can be prepared according to a conventional method from external preparations such as lotions, tonics, creams, ointments and aerosols.

【0010】本発明の育毛剤は、1日1〜数回適量を頭
皮に塗布して使用する。
The hair restorer of the present invention is applied to the scalp in an appropriate amount once to several times a day for use.

【0011】[0011]

【発明の効果】後記試験例から明らかなように、本発明
によりミノキシジルの経皮吸収性を高めた育毛剤を提供
することが可能になった。
As is apparent from the test examples described below, the present invention has made it possible to provide a hair-growing agent with improved transdermal absorbability of minoxidil.

【0012】[0012]

【実施例】以下、実施例および試験例に基づいて本発明
を詳細に説明する。
EXAMPLES The present invention will be described in detail below based on examples and test examples.

【0013】実施例1 エタノール80重量部にミノキシジル0.5重量部、α
−モノイソステアリルグリセリルエーテル2重量%、精
製水17.5重量部を加えて撹拌溶解し、ローションタ
イプの育毛剤を調製した。
Example 1 80 parts by weight of ethanol, 0.5 parts by weight of minoxidil, α
-2% by weight of monoisostearyl glyceryl ether and 17.5 parts by weight of purified water were added and dissolved by stirring to prepare a lotion type hair restorer.

【0014】実施例1記載の調整方法に準じ、表1に示
す処方で実施例2〜4および対照例1、2の育毛剤を調
製した。
According to the adjusting method described in Example 1, the hair-growing agents of Examples 2 to 4 and Control Examples 1 and 2 were prepared according to the formulations shown in Table 1.

【0015】[0015]

【表1】 [Table 1]

【0016】実施例5 精製水42.7重量部にカルボキシビニルポリマー0.
4重量部を撹拌しながら分散させた。これに、エタノー
ル40重量部、1,3−ブタンジオール5重量部、ミノ
キシジル1重量部、α−モノイソステアリルグリセリル
エーテル10重量部、L−メントール0.5重量部およ
びジイソプロパノールアミン0.4重量部を撹拌溶解さ
せた液を添加し、撹拌混合して、ゲルタイプの育毛剤を
調製した。
Example 5 42.7 parts by weight of purified water were mixed with 0.
4 parts by weight were dispersed with stirring. 40 parts by weight of ethanol, 5 parts by weight of 1,3-butanediol, 1 part by weight of minoxidil, 10 parts by weight of α-monoisostearyl glyceryl ether, 0.5 part by weight of L-menthol and 0.4 part by weight of diisopropanolamine. A solution in which the parts were dissolved by stirring was added and mixed by stirring to prepare a gel-type hair restorer.

【0017】実施例6 ポリオキシエチレン(20)ソルビタンモノステアレー
ト5重量部、ソルビタンモノステアレート3重量部、セ
タノール2重量部、ステアリルアルコール2重量部、流
動パラフィン10重量部およびビタミンEアセテート
0.2重量部、α−モノイソステアリルグリセリルエー
テル2重量部を加温しながら混合溶解した。別に、ミノ
キシジル1重量部、ヒノキチオール0.1重量部、グリ
チルレチン酸0.2重量部、ジブチルヒドロキシトルエ
ン0.05重量部、エチレンジアミンテトラアセテート
−2ナトリウム塩0.05重量部、パラオキシ安息香酸
メチル0.05重量部、精製水74.35重量部を加温
しながら溶解撹拌した液を加え、混合撹拌しながら室温
まで冷却し、クリームタイプの育毛剤を調製した。
Example 6 Polyoxyethylene (20) sorbitan monostearate 5 parts by weight, sorbitan monostearate 3 parts by weight, cetanol 2 parts by weight, stearyl alcohol 2 parts by weight, liquid paraffin 10 parts by weight and vitamin E acetate 0. 2 parts by weight and 2 parts by weight of α-monoisostearyl glyceryl ether were mixed and dissolved while heating. Separately, 1 part by weight of minoxidil, 0.1 part by weight of hinokitiol, 0.2 part by weight of glycyrrhetinic acid, 0.05 part by weight of dibutylhydroxytoluene, 0.05 part by weight of ethylenediaminetetraacetate-2 sodium salt, methyl paraoxybenzoate of 0.1 part by weight. A solution in which 05 parts by weight and 74.35 parts by weight of purified water were dissolved and stirred while heating was added, and the mixture was cooled to room temperature with mixing and stirring to prepare a cream type hair restorer.

【0018】実施例7 ミノキシジル2重量部、パントテニールエチルエーテル
0.1重量部、センブリエキス0.1重量部、α−モノ
イソステアリルグリセリルエーテル2重量部、ポリオキ
シエチレン硬化ヒマシ油0.5重量部、エタノール60
重量部、精製水35.3重量部を撹拌溶解して、ローシ
ョンタイプの育毛剤を調製した。
Example 7 Minoxidil 2 parts by weight, pantotenyl ethyl ether 0.1 parts by weight, assembly extract 0.1 parts by weight, α-monoisostearyl glyceryl ether 2 parts by weight, polyoxyethylene hydrogenated castor oil 0.5 parts by weight. Part, ethanol 60
A lotion type hair restorer was prepared by stirring and dissolving 3 parts by weight of purified water and 35.3 parts by weight of purified water.

【0019】実施例8 ミノキシジル5重量部、プロピレングリコール10重量
部、α−モノイソステアリルグリセリルエーテル10重
量部、エタノール65重量部、精製水10重量部を混合
溶解して、ローションタイプの育毛剤を調製した。
Example 8 5 parts by weight of minoxidil, 10 parts by weight of propylene glycol, 10 parts by weight of α-monoisostearyl glyceryl ether, 65 parts by weight of ethanol and 10 parts by weight of purified water were mixed and dissolved to give a lotion type hair restorer. Prepared.

【0020】実施例9 ミノキシジル0.5重量部、グリセリン2重量部、ポリ
オキシエチレン(20)ポリオキシプロピレン(6)デ
シルテトラデシルエーテル2重量部、セイモッコウエキ
ス1重量部、ニンジンエキス0.1重量部、α−モノイ
ソステアリルグリセリルエーテル10重量部、エタノー
ル60重量部および精製水24.4重量部を撹拌溶解
し、ローションタイプの育毛剤を調製した。
Example 9 0.5 part by weight of minoxidil, 2 parts by weight of glycerin, 2 parts by weight of polyoxyethylene (20) polyoxypropylene (6) decyl tetradecyl ether, 1 part by weight of gypsum extract, and carrot extract 0.1. By weight, 10 parts by weight of α-monoisostearyl glyceryl ether, 60 parts by weight of ethanol and 24.4 parts by weight of purified water were dissolved by stirring to prepare a lotion-type hair restorer.

【0021】実施例10 ミノキシジル2重量部、エチニルエストラジオール0.
0008重量部、トウガラシチンキ0.5重量部、ニコ
チン酸アミド0.2重量部、ポリオキシエチレン(6)
モノオレエート0.5重量部、ジプロピレングリコール
4重量部、α−モノイソステアリルグリセリルエーテル
5重量部、ハッカ油0.01重量部、ジブチルヒドロキ
シトルエン0.005重量部、エタノール60重量部、
精製水27.7842重量部を撹拌溶解し、ローション
タイプの育毛剤を調製した。
Example 10 Minoxidil 2 parts by weight, ethinyl estradiol 0.
0008 parts by weight, capsicum tincture 0.5 parts by weight, nicotinic acid amide 0.2 parts by weight, polyoxyethylene (6)
0.5 parts by weight of monooleate, 4 parts by weight of dipropylene glycol, 5 parts by weight of α-monoisostearyl glyceryl ether, 0.01 part by weight of peppermint oil, 0.005 part by weight of dibutylhydroxytoluene, 60 parts by weight of ethanol,
27.7842 parts by weight of purified water was dissolved by stirring to prepare a lotion type hair restorer.

【0022】実施例11 ミノキシジル1重量部、イソプロピルメチルフェノール
0.05重量部、1,3−ブタンジオール5重量部、α
−モノイソステアリルグリセリルエーテル5重量部、ポ
リオキシエチレン(20)硬化ヒマシ油0.5重量部、
エタノール55重量部および精製水33.45重量部を
撹拌溶解した。この液50重量部をエアゾール缶に入
れ、ジメチルエーテル50重量部を加圧充填し、エアゾ
ールタイプの育毛剤を調製した。
Example 11 Minoxidil 1 part by weight, isopropylmethylphenol 0.05 part by weight, 1,3-butanediol 5 parts by weight, α
5 parts by weight of monoisostearyl glyceryl ether, 0.5 parts by weight of polyoxyethylene (20) hydrogenated castor oil,
55 parts by weight of ethanol and 33.45 parts by weight of purified water were dissolved by stirring. 50 parts by weight of this solution was placed in an aerosol can, and 50 parts by weight of dimethyl ether was charged under pressure to prepare an aerosol type hair restorer.

【0023】実施例12 ミノキシジル2重量部、グリチルレチン酸0.1重量
部、ヒノキチオール0.1重量部、ビタミンEアセテー
ト0.2重量部、パントテニールエチルエーテル0.1
5重量部、塩酸イソチペンジル0.5重量部、塩酸ピリ
ドキシン0.1重量部、プラセンタエキス0.1重量
部、ミリスチン酸オクチルドデシル0.5重量部、L−
メントール0.05重量部、グリセリルモノオレエート
1重量部、ソルビタンモノラウレート1重量部、α−モ
ノイソステアリルグリセリルエーテル20重量部、エタ
ノール50重量部および精製水24.2重量部を撹拌溶
解してローションタイプの育毛剤を調製した。
Example 12 2 parts by weight of minoxidil, 0.1 part by weight of glycyrrhetinic acid, 0.1 part by weight of hinokitiol, 0.2 part by weight of vitamin E acetate, 0.1 part of pantotenyl ethyl ether.
5 parts by weight, isothipendyl hydrochloride 0.5 part by weight, pyridoxine hydrochloride 0.1 part by weight, placenta extract 0.1 part by weight, octyldodecyl myristate 0.5 part by weight, L-
0.05 parts by weight of menthol, 1 part by weight of glyceryl monooleate, 1 part by weight of sorbitan monolaurate, 20 parts by weight of α-monoisostearyl glyceryl ether, 50 parts by weight of ethanol and 24.2 parts by weight of purified water were dissolved by stirring. To prepare a lotion type hair restorer.

【0024】実施例13 ステアリン酸2重量部、セタノール1.5重量部、白色
ワセリン3重量部、ラノリンアルコール2重量部、ポリ
オキシエチレン(10)モノオレエート2重量部、α−
モノイソステアリルグリセリルエーテル5重量部、ビタ
ミンEアセテート0.2重量部を加熱しながら混合溶解
した。これに、ミノキシジル0.5重量部、グリチルレ
チン酸0.2重量部、パラオキシ安息香酸メチル0.0
5重量部、エチレンジアミンテトラアセテート−2ナト
リウム塩0.05重量部、プロピレングリコール10重
量部、精製水73.5重量部を加熱溶解した液を加え、
混合しながら室温まで冷却し、乳液タイプの育毛剤を調
製した。
Example 13 2 parts by weight of stearic acid, 1.5 parts by weight of cetanol, 3 parts by weight of white petrolatum, 2 parts by weight of lanolin alcohol, 2 parts by weight of polyoxyethylene (10) monooleate, α-
5 parts by weight of monoisostearyl glyceryl ether and 0.2 parts by weight of vitamin E acetate were mixed and dissolved while heating. 0.5 parts by weight of minoxidil, 0.2 parts by weight of glycyrrhetinic acid, and 0.0 parts of methyl paraoxybenzoate.
5 parts by weight, 0.05 parts by weight of ethylenediamine tetraacetate-2 sodium salt, 10 parts by weight of propylene glycol, and 73.5 parts by weight of purified water were added and dissolved in a liquid,
While mixing, the mixture was cooled to room temperature to prepare an emulsion type hair restorer.

【0025】試験例[ミノキシジルの経皮吸収試験] ウイスター系ラット(7週齢,オス)の腹部皮膚を摘出
し、ガラス製拡散セル(有効面積0.95cm2)にレ
シーバー側が皮膚の裏面に接するように装着した。レシ
ーバーにはpH7.4のリン酸緩衝液3mlを加え、循
環水により37℃に保つようにした。皮膚の表面側は開
放状態とし、実施例1〜4および対照例1、2の試料を
5μl塗布し、レシーバー溶液中に透過してくるミノキ
シジル量を高速液体クロマトグラフ法により測定した。
試験結果は試験開始24時間後の透過量について、比較
例サンプルを100%とした場合の実施例サンプルの透
過量の比率(実施例1および実施例2については比較例
1と、実施例3および実施例4については比較例2とそ
れぞれ比較)で表した。その結果を表2に示す。
Test Example [Minoxidil Transdermal Absorption Test] The abdominal skin of Wistar rats (7 weeks old, male) was excised, and the receiver side was brought into contact with the back surface of the skin in a glass diffusion cell (effective area 0.95 cm 2 ). So it was installed. To the receiver, 3 ml of pH 7.4 phosphate buffer was added, and the temperature was kept at 37 ° C by circulating water. The surface side of the skin was left open, 5 μl of the samples of Examples 1 to 4 and Controls 1 and 2 were applied, and the amount of minoxidil permeated into the receiver solution was measured by a high performance liquid chromatography method.
The test result shows that the ratio of the amount of permeation of the sample of the example when the amount of the sample of the comparative example was 100% with respect to the amount of permeation 24 hours after the start of the test (for example 1 and example 2, comparative example 1, example 3 and Example 4 was described as Comparative Example 2). The results are shown in Table 2.

【0026】[0026]

【表2】 [Table 2]

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 A61K 47/04 A61K 47/04 E 47/14 47/14 E (72)発明者 漆崎 文男 東京都豊島区高田3丁目24番1号 大正製 薬株式会社内─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Internal reference number FI Technical display location A61K 47/04 A61K 47/04 E 47/14 47/14 E (72) Inventor Fumio Urushizaki Tokyo 3-24-1 Takada, Toshima-ku, Taisho Pharmaceutical Co., Ltd.

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 ミノキシジルおよび脂肪族多価アルコー
ルのモノアルキルエーテルを含有することを特徴とする
育毛剤。
1. A hair restorer containing minoxidil and a monoalkyl ether of an aliphatic polyhydric alcohol.
【請求項2】 脂肪族多価アルコールがグリセリンであ
る請求項1記載の育毛剤。
2. The hair restorer according to claim 1, wherein the aliphatic polyhydric alcohol is glycerin.
【請求項3】 脂肪族多価アルコールのモノアルキルエ
ーテルがα−モノイソステアリルグリセリルエーテルで
ある請求項1記載の育毛剤。
3. The hair restorer according to claim 1, wherein the monoalkyl ether of the aliphatic polyhydric alcohol is α-monoisostearyl glyceryl ether.
JP7082122A 1995-04-07 1995-04-07 Revitalizing hair tonic Pending JPH08277209A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP7082122A JPH08277209A (en) 1995-04-07 1995-04-07 Revitalizing hair tonic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7082122A JPH08277209A (en) 1995-04-07 1995-04-07 Revitalizing hair tonic

Publications (1)

Publication Number Publication Date
JPH08277209A true JPH08277209A (en) 1996-10-22

Family

ID=13765617

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7082122A Pending JPH08277209A (en) 1995-04-07 1995-04-07 Revitalizing hair tonic

Country Status (1)

Country Link
JP (1) JPH08277209A (en)

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998032417A1 (en) * 1997-01-23 1998-07-30 Taisho Pharmaceutical Co., Ltd. Persistent hair tonic
JPH10265343A (en) * 1997-01-23 1998-10-06 Taisho Pharmaceut Co Ltd Sustained release hair growing agent
WO2001076540A1 (en) * 2000-04-07 2001-10-18 Taisho Pharmaceutical Co. Ltd. Hair growth stimulant compositions
JP2005206536A (en) * 2004-01-23 2005-08-04 Kao Corp Hair-growing agent
JP2006022091A (en) * 2004-06-09 2006-01-26 Dai Ichi Seiyaku Co Ltd Composition for growing hair
JP2007320873A (en) * 2006-05-31 2007-12-13 Mandom Corp Antiseptic sterilizable composition
JP2009215323A (en) * 2004-06-09 2009-09-24 Daiichi Sankyo Healthcare Co Ltd New hair growing composition
JP2016138094A (en) * 2015-01-23 2016-08-04 大正製薬株式会社 External composition
US9622947B2 (en) 2002-10-25 2017-04-18 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9636405B2 (en) 2003-08-04 2017-05-02 Foamix Pharmaceuticals Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9662298B2 (en) 2007-08-07 2017-05-30 Foamix Pharmaceuticals Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US9675700B2 (en) 2009-10-02 2017-06-13 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US9682021B2 (en) 2006-11-14 2017-06-20 Foamix Pharmaceuticals Ltd. Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US9713643B2 (en) 2002-10-25 2017-07-25 Foamix Pharmaceuticals Ltd. Foamable carriers
US9795564B2 (en) 2007-12-07 2017-10-24 Foamix Pharmaceuticals Ltd. Oil-based foamable carriers and formulations
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US9884017B2 (en) 2009-04-28 2018-02-06 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US10092588B2 (en) 2009-07-29 2018-10-09 Foamix Pharmaceuticals Ltd. Foamable compositions, breakable foams and their uses
US10322085B2 (en) 2002-10-25 2019-06-18 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US10350166B2 (en) 2009-07-29 2019-07-16 Foamix Pharmaceuticals Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
JP2020007280A (en) * 2018-07-11 2020-01-16 花王株式会社 Hair restorer
US10821077B2 (en) 2002-10-25 2020-11-03 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof

Cited By (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998032417A1 (en) * 1997-01-23 1998-07-30 Taisho Pharmaceutical Co., Ltd. Persistent hair tonic
JPH10265343A (en) * 1997-01-23 1998-10-06 Taisho Pharmaceut Co Ltd Sustained release hair growing agent
AU729411B2 (en) * 1997-01-23 2001-02-01 Taisho Pharmaceutical Co., Ltd. Sustained release hair growth preparation
US6255313B1 (en) 1997-01-23 2001-07-03 Taisho Pharmaceutical Co., Ltd. Sustained release hair growth composition
WO2001076540A1 (en) * 2000-04-07 2001-10-18 Taisho Pharmaceutical Co. Ltd. Hair growth stimulant compositions
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US10322085B2 (en) 2002-10-25 2019-06-18 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US10821077B2 (en) 2002-10-25 2020-11-03 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US11033491B2 (en) 2002-10-25 2021-06-15 Vyne Therapeutics Inc. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9622947B2 (en) 2002-10-25 2017-04-18 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9713643B2 (en) 2002-10-25 2017-07-25 Foamix Pharmaceuticals Ltd. Foamable carriers
US9636405B2 (en) 2003-08-04 2017-05-02 Foamix Pharmaceuticals Ltd. Foamable vehicle and pharmaceutical compositions thereof
JP2005206536A (en) * 2004-01-23 2005-08-04 Kao Corp Hair-growing agent
JP2009215323A (en) * 2004-06-09 2009-09-24 Daiichi Sankyo Healthcare Co Ltd New hair growing composition
JP2006022091A (en) * 2004-06-09 2006-01-26 Dai Ichi Seiyaku Co Ltd Composition for growing hair
JP2007320873A (en) * 2006-05-31 2007-12-13 Mandom Corp Antiseptic sterilizable composition
US9682021B2 (en) 2006-11-14 2017-06-20 Foamix Pharmaceuticals Ltd. Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US11103454B2 (en) 2007-08-07 2021-08-31 Vyne Therapeutics Inc. Wax foamable vehicle and pharmaceutical compositions thereof
US9662298B2 (en) 2007-08-07 2017-05-30 Foamix Pharmaceuticals Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US10369102B2 (en) 2007-08-07 2019-08-06 Foamix Pharmaceuticals Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9795564B2 (en) 2007-12-07 2017-10-24 Foamix Pharmaceuticals Ltd. Oil-based foamable carriers and formulations
US11433025B2 (en) 2007-12-07 2022-09-06 Vyne Therapeutics Inc. Oil foamable carriers and formulations
US10213384B2 (en) 2009-04-28 2019-02-26 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US9884017B2 (en) 2009-04-28 2018-02-06 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US10588858B2 (en) 2009-04-28 2020-03-17 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US10363216B2 (en) 2009-04-28 2019-07-30 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US10350166B2 (en) 2009-07-29 2019-07-16 Foamix Pharmaceuticals Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US10092588B2 (en) 2009-07-29 2018-10-09 Foamix Pharmaceuticals Ltd. Foamable compositions, breakable foams and their uses
US11219631B2 (en) 2009-07-29 2022-01-11 Vyne Pharmaceuticals Inc. Foamable compositions, breakable foams and their uses
US10517882B2 (en) 2009-10-02 2019-12-31 Foamix Pharmaceuticals Ltd. Method for healing of an infected acne lesion without scarring
US10821187B2 (en) 2009-10-02 2020-11-03 Foamix Pharmaceuticals Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US10322186B2 (en) 2009-10-02 2019-06-18 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10029013B2 (en) 2009-10-02 2018-07-24 Foamix Pharmaceuticals Ltd. Surfactant-free, water-free formable composition and breakable foams and their uses
US10213512B2 (en) 2009-10-02 2019-02-26 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10463742B2 (en) 2009-10-02 2019-11-05 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10137200B2 (en) 2009-10-02 2018-11-27 Foamix Pharmaceuticals Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US9675700B2 (en) 2009-10-02 2017-06-13 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10265404B2 (en) 2009-10-02 2019-04-23 Foamix Pharmaceuticals Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US10610599B2 (en) 2009-10-02 2020-04-07 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10238746B2 (en) 2009-10-02 2019-03-26 Foamix Pharmaceuticals Ltd Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US10086080B2 (en) 2009-10-02 2018-10-02 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10835613B2 (en) 2009-10-02 2020-11-17 Foamix Pharmaceuticals Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US10946101B2 (en) 2009-10-02 2021-03-16 Vyne Therapeutics Inc. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US10967063B2 (en) 2009-10-02 2021-04-06 Vyne Therapeutics Inc. Surfactant-free, water-free formable composition and breakable foams and their uses
JP2016138094A (en) * 2015-01-23 2016-08-04 大正製薬株式会社 External composition
US10849847B2 (en) 2016-09-08 2020-12-01 Foamix Pharamaceuticals Ltd. Compositions and methods for treating rosacea and acne
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
US11324691B2 (en) 2016-09-08 2022-05-10 Journey Medical Corporation Compositions and methods for treating rosacea and acne
JP2020007280A (en) * 2018-07-11 2020-01-16 花王株式会社 Hair restorer

Similar Documents

Publication Publication Date Title
JPH08277209A (en) Revitalizing hair tonic
JPH07316023A (en) Hair tonic
JP4940527B2 (en) Sustainable hair growth composition
JP4554805B2 (en) Hair nourishing
JP2001288043A (en) Composition for scalp and hair
JPH10218737A (en) Hair grower
WO1989002731A1 (en) Hair tonic
JPH07316022A (en) Hair tonic
JP2810040B2 (en) Hair restorer for scalp and hair
JP2001288048A (en) Composition for scalp and hair
JP2001288046A (en) Composition for scalp and hair
JPH04305519A (en) Skin humectant for external use
JPH10279437A (en) Hair cosmetic
JP2001288045A (en) Composition for scalp and hair
JPH09241137A (en) Hair crowing and restoring agent
JPH08113516A (en) Composition for scalp
JPH11302133A (en) Cosmetic for scalp and hair
JPH0971513A (en) Hair tonic
JP2969866B2 (en) Hair growth agent
EP0679385B1 (en) Hair revitalizing composition
JPH0640858A (en) Hair tonic
JPH07206647A (en) Hair tonic
JPH0920613A (en) Cosmetic
JP2004059470A (en) Hair tonic
JP2814090B2 (en) Hair restoration